TNFAIP3/A20 dysfunction drives innate and sterile hyperinflammation - Report - MDSpire

Dysfunction of TNFAIP3/A20 Promotes Innate and Non-Infectious Hyperinflammatory Responses

  • By

  • Karel F. A. Van Damme

  • Pieter Hertens

  • Dorine Sichien

  • Katrien Van der Borght

  • Justine Van Moorleghem

  • Sofie De Prijck

  • Alex Klarenbeek

  • Els Louagie

  • Inés Lammens

  • Stijn Vanhee

  • Christian Vanhove

  • Pieter De Bleser

  • Steven Van Laecke

  • Amélie Dendooven

  • Hamida Hammad

  • Lars Vereecke

  • Dirk Elewaut

  • Geert van Loo

  • Bart N. Lambrecht

  • July 17, 2026

Share

Clinical Report: Dysfunction of TNFAIP3/A20 Promotes Hyperinflammatory Responses

Overview

This study investigates the role of TNFAIP3 (A20) in regulating inflammation and the consequences of its dysfunction leading to hyperinflammatory responses. Systemic inflammation due to Tnfaip3 deficiency occurs independently of autoreactive antibodies and the gut microbiome.

Background

The TNFAIP3 gene encodes a protein that regulates inflammation and prevents excessive tissue damage. Dysregulation of TNFAIP3 is associated with diseases characterized by inappropriate inflammation, including autoimmune and autoinflammatory disorders. Understanding the mechanisms behind TNFAIP3 dysfunction is important for further research into these conditions.

Data Highlights

No numerical data or trial data were provided in the source material.

Key Findings

  • TNFAIP3 serves as a crucial brake on inflammation, and its deficiency leads to systemic inflammation.
  • Systemic inflammation from Tnfaip3 deficiency occurs independently of autoreactive antibodies, B cells, and T cells.
  • The gut microbiome is not necessary for the disease manifestations observed in Tnfaip3-deficient models.
  • Autoantibodies may be a downstream consequence of disease rather than a causative factor.
  • This study suggests an autoinflammatory rather than autoimmune pathology in TNFAIP3-associated diseases.

Clinical Implications

The findings indicate that TNFAIP3-associated diseases may involve autoinflammatory mechanisms. Understanding the role of TNFAIP3 in inflammation could inform future research directions.

Conclusion

This research highlights the role of TNFAIP3 in immune regulation and indicates that its dysfunction leads to significant inflammatory responses independent of typical autoimmune mechanisms.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Dysfunction of TNFAIP3/A20 Promotes Innate and Non-Infectious Hyperinflammatory Responses
  2. Frontiers in Immunology — TIFA: a signaling hub linking inflammation, innate immunity, and human disease
  3. Blood Cancer Journal — Targeting the Inflammasome for Therapy in Myeloid Cancers
  4. Frontiers in Immunology — TLR7/9-mediated mucosal innate immune dysregulation in IgA nephropathy
  5. Frontiers in Immunology — Shared inflammatory architecture and therapeutic tensions between psoriasis and Crohn’s disease
  6. Human inborn errors of immunity: 2024 Update on the classification from the International Union of
  7. Recommendations Management | EULAR
  8. Multicenter international cohort study of HA20 reveals novel genetic architecture and phenotypic evolution | medRxiv

Original Source(s)

TNFAIP3/A20 dysfunction drives innate and sterile hyperinflammation

  • by Karel F. A. Van Damme, Pieter Hertens, Dorine Sichien, Katrien Van der Borght, Justine Van Moorleghem, Sofie De Prijck, Alex Klarenbeek, Els Louagie, Inés Lammens, Stijn Vanhee, Christian Vanhove, Pieter De Bleser, Steven Van Laecke, Amélie Dendooven, Hamida Hammad, Lars Vereecke, Dirk Elewaut, Geert van Loo, Bart N. Lambrecht

  • July 17, 2026

Related Content

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

Serostatus May Modify RA Activity–CV Link

Combined rheumatoid factor and anticitrullinated protein antibody status appeared to modify the association between baseline rheumatoid arthritis disease activity and subsequent cardiovascular events in an international observational cohort.

Coordinated oral–gut microbiota relocation in connective tissue diseases: a systematic review